CCR5 Co-receptor Antagonist [EPC]

2294 reported adverse events

Drugs of this class: MARAVIROC

These side effects are most commonly reported by patients taking drugs of the CCR5 Co-receptor Antagonist [EPC] class:

# Side effect Count
0 VIROLOGIC FAILURE 141
1 VIRAL MUTATION IDENTIFIED 128
2 PATHOGEN RESISTANCE 125
3 PAIN 95
4 ANXIETY 94
5 OFF LABEL USE 94
6 DRUG INEFFECTIVE 93
7 DRUG INTERACTION 86
8 DRUG RESISTANCE 85
9 EMOTIONAL DISTRESS 73
See all common reactions for CCR5 Co-receptor Antagonist [EPC]

Drugs of the CCR5 Co-receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC 8 0.2162
1 CSF HIV ESCAPE SYNDROME 15 0.1087
2 CONGENITAL URETERIC ANOMALY 6 0.0968
3 CONGENITAL VESICOURETERIC REFLUX 7 0.0814
4 CONGENITAL BLADDER ANOMALY 7 0.0519
5 HIV VIRAEMIA 8 0.0381
6 VIRAL MUTATION IDENTIFIED 128 0.0347
7 VIRAL LOAD ABNORMAL 6 0.0343
8 CONGENITAL RENAL DISORDER 8 0.0301
9 MITOCHONDRIAL MYOPATHY 6 0.0275
See all enriched reactions for CCR5 Co-receptor Antagonist [EPC]